Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol >=190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry [Original Articles]
Conclusions:
Evidence-based LLT use remains low among patients with elevated LDL-C with significant variation in care. System-level interventions are needed to address these gaps and reduce variation in care of these high-risk patients.
Source: Circulation: Cardiovascular Quality and Outcomes - Category: Cardiology Authors: Virani, S. S., Kennedy, K. F., Akeroyd, J. M., Morris, P. B., Bittner, V. A., Masoudi, F. A., Stone, N. J., Petersen, L. A., Ballantyne, C. M. Tags: Lipids and Cholesterol, Cardiovascular Disease, Quality and Outcomes Original Articles Source Type: research